Adaptimmune Therapeutics Plc Overview
Adaptimmune Therapeutics Plc Discounted Cash Flow
DCF Analysis for ADAP.
Get informed when a big investor buys or sells
+ FollowFair Value
$2.33
Current Fair Value
$2.33
↑ 4709.1% Upside
Undervalued by 4709.1% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison